GRAIL
PublicGRAIL is now publicly traded
The data on this page reflects GRAIL's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Strategic
Oct 16, 2025
Total Funding Raised
$10.1B
Company Overview
Grail is a healthcare company specializing in technologies for early cancer detection, offering a multi-cancer early detection blood test capable of identifying various types of cancer at all stages.
Sector
Healthcare
AI Layer
Application
Keywords
GRAIL Comparables
Compare GRAIL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harbinger Health | 74% | |
| Lucence | 71% | |
| SeekIn Inc. | 71% |
GRAIL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 16, 2025 | ||||
| M&A | Aug 18, 2021 | ||||
| Series D | May 6, 2020 | ||||
| Series C | May 21, 2018 | ||||
| Series B | Nov 22, 2017 | ||||
Series A | Jan 10, 2016 |
GRAIL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CPP Investments | Series D |
| GV | Series A |
| Hillhouse Investment | Series C |
| Blue Pool Capital | Series C |
| Waycross Ventures | Series A |
| Ally Bridge Group | Series C |
| Huangpu River Capital | Series C |
GRAIL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access